Yvonne Heimann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yvonne Heimann has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Tanja Groten
Medizinische Fakultät, Universität zu Köln, Germany
7 shared publications - Friederike Weschenfelder
Department of Obstetrics, University Hospital Jena, Friedrich Schiller University, Am Klinikum 1, 07747 Jena, Germany
5 shared publications - Ekkehard Schleußner
Department of Obstetrics, University Hospital Jena, Friedrich Schiller University, Am Klinikum 1, 07747 Jena, Germany
4 shared publications E Schleußner
UKJ, Klinik für Geburtsmedizin, Jena, Deutschland
2 shared publicationsEkkehard Schleußner
Department of Obstetrics, University Hospital Jena, Friedrich Schiller University Jena, Jena, Germany
2 shared publicationsA Kolterer
Universitätsklinikum Jena, Klinik für Geburtsmedizin, Jena, Deutschland
1 shared publication
Latest Publications
- Open Access
- 29 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (15) , 5919
Association Between HbA1c Levels and Postpartum Depressive Symptoms: Insights from Edinburgh Postnatal Depression Scale Screening After Gestational Diabetes Mellitus
Background/Objectives: Depressive symptoms are more frequent following pregnancies complicated by gestational diabetes mellitus (GDM), prompting postpartum depression screening recommendations in the German S3 guideline. Although GDM is associated with increased postpartum depression risk, the relationships between postpartum metabolic parameters and the Edinburgh Postnatal Depression Scale (EPDS) scores remain unclear. We investigated whether metabolic markers measured during diabetes screening 6–12 weeks postpartum are associated with depressive symptoms. Methods: We retrospectively analyzed EPDS screenings conducted during postpartum testing at our inpatient clinic between 07/2021 and 02/2024. The EPDS is a validated 10-item tool (score range 0–30), with scores ≥10 indicating potential depression. Metabolic parameters included HbA1c, the 75 g oral glucose tolerance test (oGTT), insulin, and the Homeostasis Model Assessment index (HOMA index). Group comparisons were performed using non-parametric tests and receiver operating characteristic (ROC) analyses, with the Youden index identifying optimal cutoffs. Results: Among the 102 women presenting for postpartum testing, 43.1% had normal glucose tolerance, 54.9% prediabetes, and 2.0% diabetes. A total of 13.7% (n = 14) screened positive for potential depression, including two who reported suicidal ideations. Women with positive EPDS scores had significantly higher HbA1c [5.7% (38.3 mmol/mol) vs. 5.4% (35.5 mmol/mol), p = 0.013]. An HbA1c cutoff of 5.42% (35.75 mmol/mol) showed discriminatory ability for depressive symptoms with an Area Under the Curve (AUC) of 0.708 (CI 0.567–0.849). Other metabolic parameters showed no significant associations. Conclusions: Elevated postpartum HbA1c is associated with depressive symptoms after GDM pregnancies. An HbA1c threshold of 5.42% (35.75 mmol/mol) may help identify women at increased postpartum depression risk and prompt subsequent psychological assessment when depression screening is otherwise omitted.
- 29 July 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (15) , 5919
Open AccessAssociation Between HbA1c Levels and Postpartum Depressive Symptoms: Insights from Edinburgh Postnatal Depression Scale Screening After Gestational Diabetes Mellitus
Background/Objectives: Depressive symptoms are more frequent following pregnancies complicated by gestational diabetes mellitus (GDM), prompting postpartum depression screening recommendations in the German S3 guideline. Although GDM is associated with increased postpartum depression risk, the relationships between postpartum metabolic parameters and the Edinburgh Postnatal Depression Scale (EPDS) scores remain unclear. We investigated whether metabolic markers measured during diabetes screening 6–12 weeks postpartum are associated with depressive symptoms. Methods: We retrospectively analyzed EPDS screenings conducted during postpartum testing at our inpatient clinic between 07/2021 and 02/2024. The EPDS is a validated 10-item tool (score range 0–30), with scores ≥10 indicating potential depression. Metabolic parameters included HbA1c, the 75 g oral glucose tolerance test (oGTT), insulin, and the Homeostasis Model Assessment index (HOMA index). Group comparisons were performed using non-parametric tests and receiver operating characteristic (ROC) analyses, with the Youden index identifying optimal cutoffs. Results: Among the 102 women presenting for postpartum testing, 43.1% had normal glucose tolerance, 54.9% prediabetes, and 2.0% diabetes. A total of 13.7% (n = 14) screened positive for potential depression, including two who reported suicidal ideations. Women with positive EPDS scores had significantly higher HbA1c [5.7% (38.3 mmol/mol) vs. 5.4% (35.5 mmol/mol), p = 0.013]. An HbA1c cutoff of 5.42% (35.75 mmol/mol) showed discriminatory ability for depressive symptoms with an Area Under the Curve (AUC) of 0.708 (CI 0.567–0.849). Other metabolic parameters showed no significant associations. Conclusions: Elevated postpartum HbA1c is associated with depressive symptoms after GDM pregnancies. An HbA1c threshold of 5.42% (35.75 mmol/mol) may help identify women at increased postpartum depression risk and prompt subsequent psychological assessment when depression screening is otherwise omitted.
- Open Access
- 15 July 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (7) , e0344378
Impact of blood pressure control during pregnancy on long-term maternal cardiovascular health - secondary analysis of a follow-up study 15 years post preeclampsia (PAVA study).
Within the PAVA study, we investigated placenta-associated vascular aging in women 15 years after pregnancies complicated by preeclampsia and/or fetal growth restriction. During these pregnancies, blood pressure values >140/90 mmHg were considered to require treatment. Following evidence demonstrating improved pregnancy outcomes with tighter blood pressure control, updated German and international guidelines (International Society for the Study of Hypertension in Pregnancy, ISSHP) now recommend target values below 135/85 mmHg. To evaluate whether blood pressure levels during pregnancy are associated with long-term maternal cardiovascular health, we analyzed the impact of blood pressure control during pregnancy on cardiovascular risk profiles obtained in the PAVA follow-up study. Between August 2019 and December 2022, 53 women were examined an average of 15 years after experiencing preeclampsia and/or fetal growth restriction. At the study visit, baseline data were collected, and a comprehensive clinical and functional assessment was performed. This analysis compared 35 women who were hypertensive at follow-up (blood pressure ≥140/90 mmHg and/or antihypertensive medication) with 18 normotensive participants (blood pressure <140/90 mmHg and no antihypertensive medication). Data on blood pressure levels during pregnancy were collected retrospectively from medical records. Blood pressure data during pregnancy were available for the second trimester in 15 women who later developed hypertension and 4 who remained normotensive, and for the third trimester in 19 and 14 participants, respectively. Data from the first trimester were not available. In group comparisons, systolic blood pressure in the second trimester and diastolic blood pressure in the third trimester were significantly higher in women who were hypertensive at follow-up (155 vs. 140 mmHg, p = 0.027; 96 vs. 87 mmHg, p = 0.026). In adjusted analyses, no statistically significant associations were observed; however, effect estimates suggested a potential association between blood pressure control during pregnancy and lower odds of later arterial hypertension (OR 0.22, 95% CI 0.03-1.53) and concentric remodeling (OR 0.37, 95% CI 0.03-4.29). These findings suggest that blood pressure levels during pregnancy may be associated with long-term maternal cardiovascular health. However, given the limited sample size and exploratory nature of the analysis, these results should be interpreted with caution and require confirmation in larger prospective studies.
- 15 July 2026
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 21 (7) , e0344378
Open AccessImpact of blood pressure control during pregnancy on long-term maternal cardiovascular health - secondary analysis of a follow-up study 15 years post preeclampsia (PAVA study).
Within the PAVA study, we investigated placenta-associated vascular aging in women 15 years after pregnancies complicated by preeclampsia and/or fetal growth restriction. During these pregnancies, blood pressure values >140/90 mmHg were considered to require treatment. Following evidence demonstrating improved pregnancy outcomes with tighter blood pressure control, updated German and international guidelines (International Society for the Study of Hypertension in Pregnancy, ISSHP) now recommend target values below 135/85 mmHg. To evaluate whether blood pressure levels during pregnancy are associated with long-term maternal cardiovascular health, we analyzed the impact of blood pressure control during pregnancy on cardiovascular risk profiles obtained in the PAVA follow-up study. Between August 2019 and December 2022, 53 women were examined an average of 15 years after experiencing preeclampsia and/or fetal growth restriction. At the study visit, baseline data were collected, and a comprehensive clinical and functional assessment was performed. This analysis compared 35 women who were hypertensive at follow-up (blood pressure ≥140/90 mmHg and/or antihypertensive medication) with 18 normotensive participants (blood pressure <140/90 mmHg and no antihypertensive medication). Data on blood pressure levels during pregnancy were collected retrospectively from medical records. Blood pressure data during pregnancy were available for the second trimester in 15 women who later developed hypertension and 4 who remained normotensive, and for the third trimester in 19 and 14 participants, respectively. Data from the first trimester were not available. In group comparisons, systolic blood pressure in the second trimester and diastolic blood pressure in the third trimester were significantly higher in women who were hypertensive at follow-up (155 vs. 140 mmHg, p = 0.027; 96 vs. 87 mmHg, p = 0.026). In adjusted analyses, no statistically significant associations were observed; however, effect estimates suggested a potential association between blood pressure control during pregnancy and lower odds of later arterial hypertension (OR 0.22, 95% CI 0.03-1.53) and concentric remodeling (OR 0.37, 95% CI 0.03-4.29). These findings suggest that blood pressure levels during pregnancy may be associated with long-term maternal cardiovascular health. However, given the limited sample size and exploratory nature of the analysis, these results should be interpreted with caution and require confirmation in larger prospective studies.
- Open Access
- 29 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (13) , 5070
Diagnostic Accuracy, Sensitivity and Specificity of Capillary POCT for Diagnosing Gestational Diabetes Mellitus
Background: The 75 g oral glucose tolerance test (OGTT) is the gold standard for diagnosing gestational diabetes mellitus (GDM) and, according to current guidelines, is recommended for postpartum testing. German guidelines recommend a two-step screening approach, which can delay treatment initiation. In order to prevent complications for mother and child, treatment of GDM should be started as early as possible. To expedite clinical decisions, point-of-care testing (POCT) is often used alongside venous laboratory analysis. For historical reasons, capillary blood was used for POCT at our competence center. This analysis evaluates the diagnostic accuracy of capillary POCT compared to the venous reference standard analyzed in our department of clinical chemistry. Methods: We retrospectively analyzed 401 OGTTs (260 during pregnancy, 141 postpartum) with simultaneous capillary POCT and venous laboratory glucose measurements and investigated the agreement between the two methods. Optimal capillary cut-offs were determined using ROC analysis. Results: In pregnant women (n = 260), capillary POCT showed 80.8% sensitivity and 73.4% specificity. Regarding the diagnostic classification, the initial agreement with the reference standard at fasting was 71.9% (8.9% false positives, 19.2% false negatives). Optimized capillary cut-offs—fasting ≥95 mg/dL (5.3 mmol/L), 1-h ≥203 mg/dL (11.3 mmol/L), and 2-h ≥174 mg/dL (9.7 mmol/L)—increased the proportion of correctly classified cases to 85.5% (fasting), 97.0% (1-h), and 94.4% (2-h), respectively, and effectively eliminated false negatives. Conclusions: While capillary POCT offers >80% sensitivity, its false-positive rate of more than 20% must be managed. Utilizing optimized cut-off values can mitigate this uncertainty. If at least one of these cut-offs is exceeded, capillary POCT via StatStrip® (Nova Biomedical Corporation, Waltham, MA, USA) provides a sufficient basis for treatment initiation.
- 29 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (13) , 5070
Open AccessDiagnostic Accuracy, Sensitivity and Specificity of Capillary POCT for Diagnosing Gestational Diabetes Mellitus
Background: The 75 g oral glucose tolerance test (OGTT) is the gold standard for diagnosing gestational diabetes mellitus (GDM) and, according to current guidelines, is recommended for postpartum testing. German guidelines recommend a two-step screening approach, which can delay treatment initiation. In order to prevent complications for mother and child, treatment of GDM should be started as early as possible. To expedite clinical decisions, point-of-care testing (POCT) is often used alongside venous laboratory analysis. For historical reasons, capillary blood was used for POCT at our competence center. This analysis evaluates the diagnostic accuracy of capillary POCT compared to the venous reference standard analyzed in our department of clinical chemistry. Methods: We retrospectively analyzed 401 OGTTs (260 during pregnancy, 141 postpartum) with simultaneous capillary POCT and venous laboratory glucose measurements and investigated the agreement between the two methods. Optimal capillary cut-offs were determined using ROC analysis. Results: In pregnant women (n = 260), capillary POCT showed 80.8% sensitivity and 73.4% specificity. Regarding the diagnostic classification, the initial agreement with the reference standard at fasting was 71.9% (8.9% false positives, 19.2% false negatives). Optimized capillary cut-offs—fasting ≥95 mg/dL (5.3 mmol/L), 1-h ≥203 mg/dL (11.3 mmol/L), and 2-h ≥174 mg/dL (9.7 mmol/L)—increased the proportion of correctly classified cases to 85.5% (fasting), 97.0% (1-h), and 94.4% (2-h), respectively, and effectively eliminated false negatives. Conclusions: While capillary POCT offers >80% sensitivity, its false-positive rate of more than 20% must be managed. Utilizing optimized cut-off values can mitigate this uncertainty. If at least one of these cut-offs is exceeded, capillary POCT via StatStrip® (Nova Biomedical Corporation, Waltham, MA, USA) provides a sufficient basis for treatment initiation.
- Open Access
- 15 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (12) , 4646
Impact of Blood Pressure Levels During Pregnancy on Postpartum Hypertensive Outcomes: Insights from a Cohort Study
Background/Objectives: This cohort study aims to evaluate the association between antenatal blood pressure levels and postpartum cardiovascular outcomes in women with preeclampsia and/or fetal growth restriction (FGR). The objective of the study was to test the hypothesis that blood pressure levels during pregnancy are associated with cardiovascular health after delivery. Methods: The study was conducted at a tertiary hospital in Germany and involved women who developed preeclampsia and/or FGR during their pregnancies between 2021 and 2024. Participants were invited for cardiovascular follow-up consultations at 6 weeks and 6 months postpartum. VICORDER measurements were used for cardiovascular function assessment. Results were compared between the group with persisting hypertension and normotensive women at each study visit to assess the long-term progression of hypertensive disorders in relation to antenatal blood pressure levels. Statistical analysis employed Mann–Whitney U tests and adjusted odds ratios (aORs). Results: Of the 103 women who attended postpartum cardiovascular consultations during the study period, a substantial proportion still had elevated blood pressure at 6 weeks (51.49%) and 6 months (42.86%) after delivery. Women with persistent hypertension had higher systolic and diastolic blood pressure throughout pregnancy (p < 0.001), used antihypertensive medication more frequently (p < 0.001) and showed significantly increased arterial stiffness up to 6 weeks postpartum compared with normotensive women (7.4 m/s vs. 6.7 m/s, p < 0.001). In adjusted analyses, higher blood pressure levels during pregnancy were significant predictors of persistent postpartum hypertension (p < 0.05). Except for systolic blood pressure in the 3rd trimester at the 6-week follow-up, every 10 mmHg increase in blood pressure during pregnancy was associated with higher odds of postpartum hypertension, with aORs ranging from 1.82 to 3.42 at 6 weeks and from 2.18 to 5.51 at 6 months postpartum (depending on the trimester). Conclusions: Maintaining healthy blood pressure levels during pregnancy may reduce the long-term cardiovascular risk for mothers. These findings underscore the importance of early detection and consistent management of hypertension in expectant mothers with hypertensive pregnancy disorders. Further research is required to identify optimal blood pressure management strategies during pregnancy that could improve immediate and long-term maternal health outcomes.
- 15 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (12) , 4646
Open AccessImpact of Blood Pressure Levels During Pregnancy on Postpartum Hypertensive Outcomes: Insights from a Cohort Study
Background/Objectives: This cohort study aims to evaluate the association between antenatal blood pressure levels and postpartum cardiovascular outcomes in women with preeclampsia and/or fetal growth restriction (FGR). The objective of the study was to test the hypothesis that blood pressure levels during pregnancy are associated with cardiovascular health after delivery. Methods: The study was conducted at a tertiary hospital in Germany and involved women who developed preeclampsia and/or FGR during their pregnancies between 2021 and 2024. Participants were invited for cardiovascular follow-up consultations at 6 weeks and 6 months postpartum. VICORDER measurements were used for cardiovascular function assessment. Results were compared between the group with persisting hypertension and normotensive women at each study visit to assess the long-term progression of hypertensive disorders in relation to antenatal blood pressure levels. Statistical analysis employed Mann–Whitney U tests and adjusted odds ratios (aORs). Results: Of the 103 women who attended postpartum cardiovascular consultations during the study period, a substantial proportion still had elevated blood pressure at 6 weeks (51.49%) and 6 months (42.86%) after delivery. Women with persistent hypertension had higher systolic and diastolic blood pressure throughout pregnancy (p < 0.001), used antihypertensive medication more frequently (p < 0.001) and showed significantly increased arterial stiffness up to 6 weeks postpartum compared with normotensive women (7.4 m/s vs. 6.7 m/s, p < 0.001). In adjusted analyses, higher blood pressure levels during pregnancy were significant predictors of persistent postpartum hypertension (p < 0.05). Except for systolic blood pressure in the 3rd trimester at the 6-week follow-up, every 10 mmHg increase in blood pressure during pregnancy was associated with higher odds of postpartum hypertension, with aORs ranging from 1.82 to 3.42 at 6 weeks and from 2.18 to 5.51 at 6 months postpartum (depending on the trimester). Conclusions: Maintaining healthy blood pressure levels during pregnancy may reduce the long-term cardiovascular risk for mothers. These findings underscore the importance of early detection and consistent management of hypertension in expectant mothers with hypertensive pregnancy disorders. Further research is required to identify optimal blood pressure management strategies during pregnancy that could improve immediate and long-term maternal health outcomes.
- Open Access
- 9 October 2025
- Published by Georg Thieme Verlag KG in Geburtshilfe und Frauenheilkunde
- Vol. 85 (12) , 1334-1341
Individual Prediction of Insulin Therapy in Gestational Diabetes: Development of a Risk Calculator Based on Real-World Data from the GestDiab Registry
The prevalence of gestational diabetes mellitus in Germany is approximately 10%. One third of affected women require insulin therapy when conservative measures such as dietary changes and physical activity are insufficient to achieve target glucose levels. Timely initiation of insulin therapy is crucial for optimising obstetric outcomes. Early identification of high-risk patients at the time of diagnosis would facilitate prompt and individualised treatment adjustments. A risk calculator was developed based on clinical parameters and medical history information to estimate the individual risk for insulin therapy. The models were derived from real-world data of the GestDiab registry, comprising 14157 pregnancies between 2018 and 2020, of which 4319 (30.5%) required insulin therapy. Various models incorporating maternal age, gestational age at diagnosis, parity, gravidity, body mass index, 75 g oral glucose tolerance test values, HbA1c levels, history of gestational diabetes mellitus, and family history of diabetes were developed. Validation using the GestDiab cohort from 2021 demonstrated that the model including all variables exhibited the highest predictive power (AUC 0.740). The risk calculator is provided online to support both patients and physicians in making informed decisions. Individualised counselling based on personal risk assessments may enhance therapy adherence and potentially reduce the necessity for insulin therapy. Die Prävalenz des Gestationsdiabetes mellitus beträgt in Deutschland etwa 10%. Bei rund einem Drittel der betroffenen Frauen ist eine Insulintherapie erforderlich, wenn konservative Maßnahmen wie Ernährungsumstellung und körperliche Aktivität nicht ausreichen, um die angestrebten Blutzuckerziele zu erreichen. Eine zeitgerechte Einleitung der Insulintherapie ist entscheidend für die Optimierung des geburtshilflichen Outcomes. Die frühzeitige Identifizierung von Hochrisikopatientinnen zum Zeitpunkt der Diagnosestellung kann eine umgehende und individualisierte Anpassung der Therapie ermöglichen. Es wurde ein Risikorechner entwickelt, der auf klinischen Parametern und anamnestischen Angaben basiert, um das individuelle Risiko für die Notwendigkeit einer Insulintherapie zu schätzen. Die Modelle wurden anhand von Real-World-Daten des GestDiab-Registers erstellt, das 14157 Schwangerschaften zwischen 2018 und 2020 umfasst. In 4319 Fällen (30,5%) war eine Insulintherapie erforderlich. Es wurden verschiedene Modelle entwickelt, die folgende Parameter einbeziehen: maternales Alter, Gestationsalter bei Diagnosestellung, Parität, Gravidität, Body-Mass-Index, Werte des 75-g-oralen Glukosetoleranztests, HbA1c, anamnestischer Gestationsdiabetes sowie familiäre Diabetesbelastung. Die Validierung anhand der GestDiab-Kohorte von 2021 zeigte, dass das Modell unter Einbeziehung sämtlicher Variablen die höchste prädiktive Genauigkeit erreichte (AUC = 0,740). Der Risikorechner wird online bereitgestellt, um sowohl Patientinnen als auch behandelnde Ärztinnen und Ärzte bei fundierten Therapieentscheidungen zu unterstützen. Eine individualisierte Beratung auf Grundlage der persönlichen Risikoeinschätzung könnte die Therapieadhärenz verbessern und potenziell die Notwendigkeit einer Insulintherapie verringern. Received: 25 February 2025 Accepted after revision: 13 July 2025 Article published online: 09 October 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 9 October 2025
- Published by Georg Thieme Verlag KG in Geburtshilfe und Frauenheilkunde
- Vol. 85 (12) , 1334-1341
Open AccessIndividual Prediction of Insulin Therapy in Gestational Diabetes: Development of a Risk Calculator Based on Real-World Data from the GestDiab Registry
The prevalence of gestational diabetes mellitus in Germany is approximately 10%. One third of affected women require insulin therapy when conservative measures such as dietary changes and physical activity are insufficient to achieve target glucose levels. Timely initiation of insulin therapy is crucial for optimising obstetric outcomes. Early identification of high-risk patients at the time of diagnosis would facilitate prompt and individualised treatment adjustments. A risk calculator was developed based on clinical parameters and medical history information to estimate the individual risk for insulin therapy. The models were derived from real-world data of the GestDiab registry, comprising 14157 pregnancies between 2018 and 2020, of which 4319 (30.5%) required insulin therapy. Various models incorporating maternal age, gestational age at diagnosis, parity, gravidity, body mass index, 75 g oral glucose tolerance test values, HbA1c levels, history of gestational diabetes mellitus, and family history of diabetes were developed. Validation using the GestDiab cohort from 2021 demonstrated that the model including all variables exhibited the highest predictive power (AUC 0.740). The risk calculator is provided online to support both patients and physicians in making informed decisions. Individualised counselling based on personal risk assessments may enhance therapy adherence and potentially reduce the necessity for insulin therapy. Die Prävalenz des Gestationsdiabetes mellitus beträgt in Deutschland etwa 10%. Bei rund einem Drittel der betroffenen Frauen ist eine Insulintherapie erforderlich, wenn konservative Maßnahmen wie Ernährungsumstellung und körperliche Aktivität nicht ausreichen, um die angestrebten Blutzuckerziele zu erreichen. Eine zeitgerechte Einleitung der Insulintherapie ist entscheidend für die Optimierung des geburtshilflichen Outcomes. Die frühzeitige Identifizierung von Hochrisikopatientinnen zum Zeitpunkt der Diagnosestellung kann eine umgehende und individualisierte Anpassung der Therapie ermöglichen. Es wurde ein Risikorechner entwickelt, der auf klinischen Parametern und anamnestischen Angaben basiert, um das individuelle Risiko für die Notwendigkeit einer Insulintherapie zu schätzen. Die Modelle wurden anhand von Real-World-Daten des GestDiab-Registers erstellt, das 14157 Schwangerschaften zwischen 2018 und 2020 umfasst. In 4319 Fällen (30,5%) war eine Insulintherapie erforderlich. Es wurden verschiedene Modelle entwickelt, die folgende Parameter einbeziehen: maternales Alter, Gestationsalter bei Diagnosestellung, Parität, Gravidität, Body-Mass-Index, Werte des 75-g-oralen Glukosetoleranztests, HbA1c, anamnestischer Gestationsdiabetes sowie familiäre Diabetesbelastung. Die Validierung anhand der GestDiab-Kohorte von 2021 zeigte, dass das Modell unter Einbeziehung sämtlicher Variablen die höchste prädiktive Genauigkeit erreichte (AUC = 0,740). Der Risikorechner wird online bereitgestellt, um sowohl Patientinnen als auch behandelnde Ärztinnen und Ärzte bei fundierten Therapieentscheidungen zu unterstützen. Eine individualisierte Beratung auf Grundlage der persönlichen Risikoeinschätzung könnte die Therapieadhärenz verbessern und potenziell die Notwendigkeit einer Insulintherapie verringern. Received: 25 February 2025 Accepted after revision: 13 July 2025 Article published online: 09 October 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 5 September 2025
- Published by Deutscher Arzte-Verlag GmbH in Deutsches Ärzteblatt international
- Vol. 122 (18) , 508-509
Climate change and premature birth
Trends in einer gemäßigten Klimazone
- 5 September 2025
- Published by Deutscher Arzte-Verlag GmbH in Deutsches Ärzteblatt international
- Vol. 122 (18) , 508-509
Climate change and premature birth
Trends in einer gemäßigten Klimazone
- Open Access
- 12 September 2024
- Published by Georg Thieme Verlag KG in Geburtshilfe und Frauenheilkunde
- Vol. 84 (11) , 1050-1056
Induction of Labor Using Castor Oil Cocktail – an Analysis of Real-world Data
Induction of labor is indicated when benefits of delivery outweigh benefits of prolonged pregnancy, which is not always welcomed by women. Castor oil is accepted as an “old household remedy” for labor induction but is not yet part of the official guidelines. Nevertheless, it is often used, mostly even before the women are admitted to the hospital. Data on its actual benefits and safety are missing. Upon accepting the real-world practice of applying castor oil cocktail for labor induction we added castor oil as one option of labor induction in our clinical routine for multiparous women at term, with a history of at least one vaginal delivery. Here we aimed to generate data on the effectivity and safety of castor oil in labor induction by analyzing the real-world data generated in our cohort.In our retrospective analysis we included data of a cohort of 148 multiparous women induced by castor oil cocktail and of 286 matched controls receiving established methods according to the current guidelines for labor induction. The castor oil cocktail was prepared following a standardized recipe with quality-tested castor oil. Statistical analysis was performed with SPSS 27.0.Perinatal outcome data including the rate of vaginal deliveries did not differ between groups, except significantly more neonates were admitted to the neonatal intensive care unit in the group receiving established methods for induction of labor (p = 0.01). In 39 women (26%), administration of castor oil cocktail alone failed to induce labor. The time from initiation of labor induction until delivery was significantly shorter in the castor oil cocktail group (p = 0.04).Our study demonstrates the safety and effectivity of a castor oil cocktail induction in multiparous women at term in a hospital-based setting using quality-controlled castor oil in a standardized recipe.
- 12 September 2024
- Published by Georg Thieme Verlag KG in Geburtshilfe und Frauenheilkunde
- Vol. 84 (11) , 1050-1056
Open AccessInduction of Labor Using Castor Oil Cocktail – an Analysis of Real-world Data
Induction of labor is indicated when benefits of delivery outweigh benefits of prolonged pregnancy, which is not always welcomed by women. Castor oil is accepted as an “old household remedy” for labor induction but is not yet part of the official guidelines. Nevertheless, it is often used, mostly even before the women are admitted to the hospital. Data on its actual benefits and safety are missing. Upon accepting the real-world practice of applying castor oil cocktail for labor induction we added castor oil as one option of labor induction in our clinical routine for multiparous women at term, with a history of at least one vaginal delivery. Here we aimed to generate data on the effectivity and safety of castor oil in labor induction by analyzing the real-world data generated in our cohort.In our retrospective analysis we included data of a cohort of 148 multiparous women induced by castor oil cocktail and of 286 matched controls receiving established methods according to the current guidelines for labor induction. The castor oil cocktail was prepared following a standardized recipe with quality-tested castor oil. Statistical analysis was performed with SPSS 27.0.Perinatal outcome data including the rate of vaginal deliveries did not differ between groups, except significantly more neonates were admitted to the neonatal intensive care unit in the group receiving established methods for induction of labor (p = 0.01). In 39 women (26%), administration of castor oil cocktail alone failed to induce labor. The time from initiation of labor induction until delivery was significantly shorter in the castor oil cocktail group (p = 0.04).Our study demonstrates the safety and effectivity of a castor oil cocktail induction in multiparous women at term in a hospital-based setting using quality-controlled castor oil in a standardized recipe.
- Open Access
- 30 November 2023
- Published by Georg Thieme Verlag KG in Geburtshilfe und Frauenheilkunde
- Vol. 83 (12) , 1500-1507
Induction of Labour with a Double Balloon Catheter – Comparison of Effectiveness of Six Versus Twelve Hours Insertion Time: a Prospective Case Control Study
Induction of labour is a common obstetric procedure to initiate or augment contractions when labour is delayed or uncertain. The double balloon catheter is a safe and effective mechanical method for cervical ripening during induction of labour. This study evaluates the effectiveness of reducing double balloon catheter insertion time from 12 to 6 hours.248 women undergoing induction with a double balloon catheter at term were divided into two groups: catheter placed for 12 hours at 8 pm in the first half of 2021 (P12) and catheter placed for 6 hours at 7 am in the second half of 2021 (P6). T-tests, chi-squared tests, and Wilcoxon signed rank test were used for statistical analysis. Primary and secondary endpoints included induction to delivery interval, prostaglandin to delivery interval, mode of delivery, and maternal and neonatal outcomes.The P6 group had a significantly reduced induction to delivery interval of 558 min (P6: 1348 min, P12: 1906 min, p < 0.01, 95% CI: 376–710) within demographically comparable groups. Multiparous women also showed a significant reduction in prostaglandin to delivery interval of 260 min (P6: 590 min, P12: 850 min, p = 0.038, 95% CI: 9–299). There were no significant differences in mode of delivery, maternal blood loss, or neonatal outcome.Reducing double balloon catheter placement time from 12 to 6 hours resulted in almost 9 hours less induction to delivery interval without adverse effects on maternal and neonatal outcome.
- 30 November 2023
- Published by Georg Thieme Verlag KG in Geburtshilfe und Frauenheilkunde
- Vol. 83 (12) , 1500-1507
Open AccessInduction of Labour with a Double Balloon Catheter – Comparison of Effectiveness of Six Versus Twelve Hours Insertion Time: a Prospective Case Control Study
Induction of labour is a common obstetric procedure to initiate or augment contractions when labour is delayed or uncertain. The double balloon catheter is a safe and effective mechanical method for cervical ripening during induction of labour. This study evaluates the effectiveness of reducing double balloon catheter insertion time from 12 to 6 hours.248 women undergoing induction with a double balloon catheter at term were divided into two groups: catheter placed for 12 hours at 8 pm in the first half of 2021 (P12) and catheter placed for 6 hours at 7 am in the second half of 2021 (P6). T-tests, chi-squared tests, and Wilcoxon signed rank test were used for statistical analysis. Primary and secondary endpoints included induction to delivery interval, prostaglandin to delivery interval, mode of delivery, and maternal and neonatal outcomes.The P6 group had a significantly reduced induction to delivery interval of 558 min (P6: 1348 min, P12: 1906 min, p < 0.01, 95% CI: 376–710) within demographically comparable groups. Multiparous women also showed a significant reduction in prostaglandin to delivery interval of 260 min (P6: 590 min, P12: 850 min, p = 0.038, 95% CI: 9–299). There were no significant differences in mode of delivery, maternal blood loss, or neonatal outcome.Reducing double balloon catheter placement time from 12 to 6 hours resulted in almost 9 hours less induction to delivery interval without adverse effects on maternal and neonatal outcome.
- Open Access
- 9 May 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (10) , 3358
Disease Perception and Mental Health in Pregnancies with Gestational Diabetes—PsychDiab Pilot Study
(1) Background: The aim of this work is to investigate the extent to which pregnant women’s well-being is burdened by the diagnosis of gestational diabetes, as well as their sensitivities and illness perceptions. Since gestational diabetes is associated with mental disorders, we hypothesized that the burden of illness might be related to pre-existing mental distress. (2) Methods: Patients treated for gestational diabetes in our outpatient clinic were retrospectively asked to complete a survey, including the self-designed Psych-Diab-Questionnaire to assess treatment satisfaction, perceived limitations in daily life and the SCL-R-90 questionnaire to assess psychological distress. The association between mental distress and well-being during treatment was analyzed. (3) Results: Of 257 patients invited to participate in the postal survey, 77 (30%) responded. Mental distress was found in 13% (n = 10) without showing other relevant baseline characteristics. Patients with abnormal SCL-R-90 scores showed higher levels of disease burden, were concerned about glucose levels as well as their child’s health, and felt less comfortable during pregnancy. (4) Conclusions: Analogous to the postpartum depression screening, screening for mental health problems during pregnancy should be considered to target psychologically distressed patients. Our Psych-Diab-Questionnaire has been shown to be suitable to assess illness perception and well-being.
- 9 May 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (10) , 3358
Open AccessDisease Perception and Mental Health in Pregnancies with Gestational Diabetes—PsychDiab Pilot Study
(1) Background: The aim of this work is to investigate the extent to which pregnant women’s well-being is burdened by the diagnosis of gestational diabetes, as well as their sensitivities and illness perceptions. Since gestational diabetes is associated with mental disorders, we hypothesized that the burden of illness might be related to pre-existing mental distress. (2) Methods: Patients treated for gestational diabetes in our outpatient clinic were retrospectively asked to complete a survey, including the self-designed Psych-Diab-Questionnaire to assess treatment satisfaction, perceived limitations in daily life and the SCL-R-90 questionnaire to assess psychological distress. The association between mental distress and well-being during treatment was analyzed. (3) Results: Of 257 patients invited to participate in the postal survey, 77 (30%) responded. Mental distress was found in 13% (n = 10) without showing other relevant baseline characteristics. Patients with abnormal SCL-R-90 scores showed higher levels of disease burden, were concerned about glucose levels as well as their child’s health, and felt less comfortable during pregnancy. (4) Conclusions: Analogous to the postpartum depression screening, screening for mental health problems during pregnancy should be considered to target psychologically distressed patients. Our Psych-Diab-Questionnaire has been shown to be suitable to assess illness perception and well-being.
- 30 September 2022
- Published by Georg Thieme Verlag KG in Geburtshilfe und Frauenheilkunde
- Vol. 82 (10) , e84
Be-Up-Subanalyse: Zusammenhang zwischen Gebärpositionen und Geburtsmodus in 2 Geburtskliniken
Einleitung Die Studie „Be-Up: Geburt aktiv“ prüfte zwischen April 2018 und Mai 2021 die unabhängige Wirksamkeit eines „alternativ ausgestatteten Gebärraumes“ auf den Geburtsmodus. Die Universitätsklinika Halle und Jena führten in diesem Setting eine Subanalyse zu Mobilität und Vertikalität der Studienteilnehmerinnen durch. Methode Analysiert wurden viertelstündliche Aufzeichnungen der Entbindungspositionen unterschieden in: Liegend-Rückenlage, Liegend-Seitenlage, Liegend-Badewanne, Vierfüßlerstand, Sitzend, Kniend und Hocke. Dabei wurden ausschließlich die letzten 3 h des Geburtsvorgangs betrachtet. Für den Mobilitätsindex wurden Änderungen zwei aufeinander folgender Positionen als 1 klassifiziert, keine Änderung als 0. So entsteht ein relativer Index: Mobilität zu Anzahl der Entbindungs-Zeiteinheiten. Dieser nimmt maximal 1 (durchgehend wechselnden Positionen) und minimal 0 (durchgehend gleichen Position) an. Zusätzlich wurde ein Vertikalitätsindex ermittelt, der Positionen anhand ihrer Neigung einteilt: Liegend (0), Vierfüßler (1), Sitzend-Kniend-Hockend (2), Stehend (3). Daraus wurde ebenfalls ein relativer Index ermittelt: Vertikalität zur Anzahl der Entbindungs-Zeiteinheiten. Dieser kann maximal 3 (durchgehend aufrechte Position) und minimal 0 (durchgehend liegende Position) erreichen. Statistische Analysen erfolgten mit dem Studentschen t-Test. Ergebnisse Analysen wurden an 576 Frauen durchgeführt, die Spontangeburtsrate lag bei 79,7 % (459/576). Es zeigten sich signifikante Unterschiede zwischen Vertikalitätsindex spontaner Entbindungen (Median: 0,75; IQR: 0,33–1,21) zu Sektiones (0,42; 0,17–0,77) (p < 0,01) bzw. zu vaginal-operativen Entbindungen (0,42; 0,00–0,92) (p < 0,01). Gleiches gilt für den Mobilitätsindex sekundärer Sektiones und vaginal-operativer Entbindungen (0,25; 0,17–0,42), die sich signifikant verschieden zu den Spontangeburten zeigten (0,33; 0,25–0,5) (p < 0,01). Diskussion Dieses Kollektiv zeigt signifikante Assoziationen zwischen Mobilität unter Geburt und Vertikalität der Gebärenden mit dem Geburtsmodus. Article published online: 11 October 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany
- 30 September 2022
- Published by Georg Thieme Verlag KG in Geburtshilfe und Frauenheilkunde
- Vol. 82 (10) , e84
Be-Up-Subanalyse: Zusammenhang zwischen Gebärpositionen und Geburtsmodus in 2 Geburtskliniken
Einleitung Die Studie „Be-Up: Geburt aktiv“ prüfte zwischen April 2018 und Mai 2021 die unabhängige Wirksamkeit eines „alternativ ausgestatteten Gebärraumes“ auf den Geburtsmodus. Die Universitätsklinika Halle und Jena führten in diesem Setting eine Subanalyse zu Mobilität und Vertikalität der Studienteilnehmerinnen durch. Methode Analysiert wurden viertelstündliche Aufzeichnungen der Entbindungspositionen unterschieden in: Liegend-Rückenlage, Liegend-Seitenlage, Liegend-Badewanne, Vierfüßlerstand, Sitzend, Kniend und Hocke. Dabei wurden ausschließlich die letzten 3 h des Geburtsvorgangs betrachtet. Für den Mobilitätsindex wurden Änderungen zwei aufeinander folgender Positionen als 1 klassifiziert, keine Änderung als 0. So entsteht ein relativer Index: Mobilität zu Anzahl der Entbindungs-Zeiteinheiten. Dieser nimmt maximal 1 (durchgehend wechselnden Positionen) und minimal 0 (durchgehend gleichen Position) an. Zusätzlich wurde ein Vertikalitätsindex ermittelt, der Positionen anhand ihrer Neigung einteilt: Liegend (0), Vierfüßler (1), Sitzend-Kniend-Hockend (2), Stehend (3). Daraus wurde ebenfalls ein relativer Index ermittelt: Vertikalität zur Anzahl der Entbindungs-Zeiteinheiten. Dieser kann maximal 3 (durchgehend aufrechte Position) und minimal 0 (durchgehend liegende Position) erreichen. Statistische Analysen erfolgten mit dem Studentschen t-Test. Ergebnisse Analysen wurden an 576 Frauen durchgeführt, die Spontangeburtsrate lag bei 79,7 % (459/576). Es zeigten sich signifikante Unterschiede zwischen Vertikalitätsindex spontaner Entbindungen (Median: 0,75; IQR: 0,33–1,21) zu Sektiones (0,42; 0,17–0,77) (p < 0,01) bzw. zu vaginal-operativen Entbindungen (0,42; 0,00–0,92) (p < 0,01). Gleiches gilt für den Mobilitätsindex sekundärer Sektiones und vaginal-operativer Entbindungen (0,25; 0,17–0,42), die sich signifikant verschieden zu den Spontangeburten zeigten (0,33; 0,25–0,5) (p < 0,01). Diskussion Dieses Kollektiv zeigt signifikante Assoziationen zwischen Mobilität unter Geburt und Vertikalität der Gebärenden mit dem Geburtsmodus. Article published online: 11 October 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany